First Bank & Trust Myriad Genetics Inc Transaction History

First Bank & Trust

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$16.45 - $25.88 $18,341 - $28,856	-1,115 Reduced 17.77%	5,159 $94,000
Q4 2021 Feb 01, 2022	BUY	$24.13 - $32.63 $17,470 - $23,624	724 Added 13.05%	6,274 $174,000
Q2 2021 Aug 10, 2021	BUY	$25.39 - $32.61 $7,159 - $9,196	282 Added 5.35%	5,550 $170,000
Q1 2021 Apr 14, 2021	BUY	$19.92 - $31.6 $37,469 - $59,439	1,881 Added 55.54%	5,268 $160,000
Q4 2020 Jan 27, 2021	SELL	$12.16 - $19.77 $1,848 - $3,005	-152 Reduced 4.29%	3,387 $67,000
Q3 2020 Oct 26, 2020	SELL	$11.25 - $14.75 $4,421 - $5,796	-393 Reduced 9.99%	3,539 $46,000
Q1 2020 Apr 14, 2020	BUY	$9.78 - $29.53 $17,124 - $51,707	1,751 Added 80.28%	3,932 $56,000
Q4 2019 Jan 31, 2020	BUY	$20.93 - $35.1 $38,971 - $65,356	1,862 Added 583.7%	2,181 $59,000
Q3 2019 Oct 17, 2019	BUY	$22.08 - $47.08 $7,043 - $15,018	319 New	319 $9,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.